메뉴 건너뛰기




Volumn 59, Issue 22 S, 1995, Pages 254-259

Fostering chemopreventive agent development: How to proceed?

Author keywords

Breast cancer; chemoprevention; intervention; lung cancer; promotion

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; VACCINE;

EID: 0029135328     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.240590832     Document Type: Article
Times cited : (8)

References (16)
  • 1
    • 0017640171 scopus 로고
    • Rationale for adjuvant chemotherapy
    • (1977) Cancer , vol.39 , pp. 2875-2882
    • Schabel, FM1
  • 2
    • 0022572833 scopus 로고
    • Body burden of cancer in relationship to therapeutic outcome: Consideration of preclinical evidence
    • (1986) Cancer Treat Rep , vol.70 , pp. 81-86
    • Griswold, DP1
  • 3
    • 84986511200 scopus 로고
    • A war not won. Sci Am
    • (1994) , pp. 130-138
    • Beardsley, T1
  • 4
    • 0026557343 scopus 로고
    • Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy.
    • (1992) Lancet , vol.339 , pp. 1-15
  • 5
    • 84986511191 scopus 로고
    • Tamoxifen's role in chemoprevention of breast cancer: An update. J Cell Biochem 20
    • (1995)
    • Nayfield, S1
  • 16
    • 84986470476 scopus 로고
    • National Cancer Advisory Board: “Cancer at a Crossroads: A Report to Congress for the Nation.” Executive Summary. pp
    • (1994) , pp. 1-34


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.